Network meta-analysis of liraglutide versus dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes in Japanese patients
Author:
Affiliation:
1. Precision Health Economics, Vancouver, BC, Canada;
2. School of Population and Public Health, University of British Columbia, Vancouver, Canada;
3. Novo Nordisk Pharma Ltd, Japan;
4. Novo Nordisk A/S, Denmark
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1345730
Reference72 articles.
1. Global Prevalence of Diabetes
2. Trends in the prevalence of type 2 diabetes and prediabetes in community-dwelling Japanese subjects: The Hisayama Study
3. P2-143 Trends in the prevalence of diabetes and diabetic retinopathy among Japanese urban population
4. Impact of population aging on trends in diabetes prevalence: A meta‐regression analysis of 160,000 Japanese adults
5. The incretin system and its role in type 2 diabetes mellitus
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of teneligliptin in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis;Frontiers in Endocrinology;2023-12-18
2. Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study;Journal of Diabetes Research;2022-01-19
3. A Review: Comparison of Efficacy of Liraglutide Versus Sitagliptin add-on-to Metformin in Type 2 Diabetes Mellitus patients;Research Journal of Pharmacy and Technology;2021-04-29
4. Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes;Journal of Obesity & Metabolic Syndrome;2021-03-30
5. Effects of liraglutide combined with metformin and Diamicron on glucose–lipid metabolism and islet β-cell function in elderly patients with type 2 diabetes mellitus;All Life;2021-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3